Page last updated: 2024-08-21

quinazolines and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

quinazolines has been researched along with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bradner, JE; Brennan, P; Bunnage, ME; Da Costa, D; Fedorov, O; Filippakopoulos, P; Fish, PV; Knapp, S; Müller, S; O'Sullivan, B; Owen, DR; Philpott, M; Picaud, S; Schwaller, J; Stankovic, T; Taniere, P; Thanasopoulou, A	1

Other Studies

1 other study(ies) available for quinazolines and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Article	Year
PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains. Cancer research, 2013, Jun-01, Volume: 73, Issue:11 Topics: Animals; Apoptosis; Cell Cycle Proteins; Cell Growth Processes; Child; Down-Regulation; Humans; Mice; Mice, Inbred NOD; Models, Molecular; Molecular Targeted Therapy; Nuclear Proteins; Phosphorylation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Interaction Mapping; Protein Structure, Tertiary; Quinazolines; Structure-Activity Relationship; Transcription Factors; Xenograft Model Antitumor Assays	2013

Article

Year

PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.

Cancer research, 2013, Jun-01, Volume: 73, Issue:11

Topics: Animals; Apoptosis; Cell Cycle Proteins; Cell Growth Processes; Child; Down-Regulation; Humans; Mice; Mice, Inbred NOD; Models, Molecular; Molecular Targeted Therapy; Nuclear Proteins; Phosphorylation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Interaction Mapping; Protein Structure, Tertiary; Quinazolines; Structure-Activity Relationship; Transcription Factors; Xenograft Model Antitumor Assays

2013